Rupture of the Device Landing Zone During Transcatheter Aortic Valve Implantation

Miralem Pašić, Axel Unbehaun, Stephan Dreysse, Semih Buz, Thorsten Drews, Marian Kukucka, Giuseppe D’Ancona, Burkhardt Seifert, Roland Hetzer

Circulation Cardiovascular Interventions · 2012 · 95 citations · 17 references

DOIFull text

Open access

Concepts

Abstract

BACKGROUND: Iatrogenic damage of different structures of the aortic root, in the region of the so-called "device landing zone," may occur during transcatheter aortic valve implantation (TAVI). It is mostly considered difficult to treat or even untreatable. METHODS AND RESULTS: We performed a retrospective analysis of the occurrence, clinical presentation, treatment, and outcome of iatrogenic rupture in the device landing zone in a series of 618 consecutive patients who underwent TAVI at our institution between April 2008 and October 2011. The incidence of rupture was 1% (6 patients). The correct diagnosis was established during TAVI procedures in 4 and postmortem in 2 patients. The major sign of the aortic rupture was apparent bleeding in 4 patients and failure of myocardial recovery after valve implantation in 1; it was asymptomatic in 1 patient. The iatrogenic rupture in the region of the device landing zone was treated surgically in 5 patients and only conservatively in the patient without symptoms. When the diagnosis was established correctly during TAVI, only 1 of 4 patients died (25%). The overall mortality rate was 50% (3 of 6 patients died). CONCLUSIONS: Rupture of different structures in the device landing zone during TAVI is a life-threatening complication that can be treated successfully if it is immediately recognized and adequately managed.

References

17